Head And Neck Cancer

A multilevel, navigation-based intervention led to more timely initiation of postoperative radiation therapy vs. usual care-based patient navigation for people with head and neck squamous cell carcinoma.

Despite focused efforts to improve the diversity of clinical trials, representation in research into head and neck cancer has become less equitable over the past decade, according to retrospective study results.

Adjuvant cemiplimab prolonged DFS compared with placebo for certain patients with cutaneous squamous cell carcinoma, according to the agent’s manufacturer.

The addition of adjuvant nivolumab to standard-of-care radiotherapy and cisplatin improved survival for patients with locally advanced squamous cell carcinoma of the head and neck.

As 2024 comes to a close, Healio is pleased to present our most widely read oncology and hematology content from the past 12 months.

Frequent daily coffee and tea drinkers are at lower risk for a variety of head and neck cancers, as well as mouth and throat-related cancers, according to data published in Cancer.

Smoking cessation within 6 months of a cancer diagnosis can significantly improve survival, according to results of a prospective study.

People with head and neck cancer experience depression twice as often as those with other types of cancer, according to results of a retrospective study.

Researchers have found evidence that the contents of an individual’s oral microbiome may be associated with their risk for head and neck cancers.

A novel drug delivery construct may protect individuals against cisplatin-induced ototoxicity and associated hearing loss.